{
    "2020-11-30": [
        [
            {
                "time": "2020-12",
                "original_text": "医疗健康行业2020年12月组合：中金医药月度7+7组合",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "中金医药",
                        "7+7组合"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业每周医览药闻：全国高耗集采 加速进口替代 推进产业创新",
                "features": {
                    "keywords": [
                        "全国高耗集采",
                        "进口替代",
                        "产业创新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：把握业绩好 确定性较强的子行业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩",
                        "确定性",
                        "子行业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：关注进口白蛋白供应情况 再次强调血制品板块性机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "进口白蛋白",
                        "血制品",
                        "板块性机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "血制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}